Article Text

PDF
08.25 In vitro characterisation of circulating fibrocytes from systemic sclerosis patients with diffuse disease: early results
  1. Stefano Soldano1,
  2. Renata Brizzolara1,
  3. Paola Montagna1,
  4. Amelia Chiara Trombetta1,
  5. Barbara Ruaro1,
  6. Paola Contini2,
  7. Alberto Sulli1,
  8. Sabrina Paolino1,
  9. Carmen Pizzorni1,
  10. Maurizio Cutolo1
  1. 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy
  2. 2Division of Clinical Immunology, Department of Internal Medicine, University of Genova, Genova, Italy

Abstract

Background Circulating fibrocytes seem an important source of fibroblasts/myofibroblasts in physiological and pathological tissue remodelling, such as in tissue repair and in fibrosing diseases (ie, systemic sclerosis, SSc).1–3 In addition, fibrocytes seem to express class II major histocompatability complex molecules (HLA-DP, -DQ, and -DR).

We aimed to isolate fibrocytes from peripheral blood mononuclear cells (PBMCs) of healthy subjects and SSc patients and to identify them using their specific markers: CD45, HLA-DR, collagen I, and the chemokine receptor CXCR4.2

Materials and methods PBMCs were collected, at basal time (t0), from 5 healthy subjects (CNTs) and 9 SSc patients, affected by diffuse disease (dSSc) and with treatment limited to vasodilators (prostacyclin) and aspirin. PBMCs isolated from 7 among the SSc patients were cultured on fibronectin-coated plates. The non-adherent cells were removed and after 8 days (t8) of culture (standardised time), the adherent cells were lifted through incubation in 0.05% EDTA (ice-cold). Fibrocyte identification (at both t0, t8), was done by fluorescence-activated cell sorter analysis (FACS), using anti-CD45, anti-collagen type I, anti-CXCR4 and HLA-DR monoclonal antibodies.

Results At basal time (t0), among the CD45+ cells, the percentage of fibrocytes, identified as triple positive (CD45+, coll I+, CXCR4+), resulted 0.44%±0.31% in healthy subjects (CNTs) and 2.10%±2.6% in SSc patients. In addition, the HLA-DR expression on fibrocytes in both CNTs and SSc patients showed low values (7.06%±6.1% and 24.2%±22.2%, respectively).

Interestingly, after 8 days (t8) of culture, fibrocytes CD45+, coll I+, CXCR4+ from the SSc patients increased up to 45.88%±23.71%, compared to basal time (t0). In addition, at t8, fibrocytes from SSc patients strongly increased HLA-DR+ expression (88.2%±24.8%).

Conclusion Fibrocytes isolated from circulating progenitor cells (CPCs) of healthy subjects and SSc patients were confirmed to express CD45, coll I and CXCR4 molecules, but in very low percentage. Already after 8 days of culture, fibrocytes (CD45+, coll I+ and CXCR4+) from SSc patients, increased up to 48% and the HLA-DR expression increased up to 64%. Additional markers for these CPCs are now under test to further characterise their phenotype(s) vs healthy controls.

References 1. Chesney J, et al. Proc Natl Acad Sci 1997;94:6307–6312;

2. Herzoga EL, et al. Experimental Haematology 2010;38:548–556.

3. Brunasso A.M. et al. F1000Research 2016;5:723.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.